Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,465 total articles
Wesdome is trading at a modest premium to its peer group on a cash-flow narrative. The trade: buy on stability and hold for a catalyst-driven re-rate tied to a resource upgrade. Entry $3.80, target $5.60, stop $3.10. Mid-term bias: primary horizon 45 trading days, extend to 180 trading days if upgraded resource and execution confirm upside.
Palo Alto Networks (PANW) sold off from a post-AI-rally high and now trades near its 10/20-day moving averages. Elevated valuation is real, but accelerating demand for AI-native security and solid free cash flow give the company room to re-earn its premium. This trade idea outlines an entry, stop and target across a 180-trading-day horizon and the …
GBTC looks primed for a mid-term pullback. With institutional flows concentrated in newly approved spot Bitcoin ETFs and technicals rolling over from recent highs, this trade idea proposes a tactical short: enter at the current level, protect with a tight stop, and target a reversion toward $50 where the 50-day momentum and the 52-week range conver…
Nokia looks attractive around $10.68 after multiple positive product wins and accelerating AI-RAN adoption. The stock sits above key moving averages, macro capex tailwinds favor network vendors, and short interest keeps rallies potent. Trade plan: enter at $10.60, stop $9.80, target $13.50 on a 45-trading-day horizon.
Berkshire Hathaway is unusually cheap for a $1.09T conglomerate with $24.2B in free cash flow and a low-debt balance sheet. Recent leadership moves and a concentrated bet on Apple and Alphabet created headline risk; we see a window to buy A-shares on strength in operating cash flow, a reasonable 12.7x P/E and bullish technicals. Trade plan: long BR…
ConocoPhillips (COP) looks like a solid play if oil stays elevated: strong free cash flow ($10.06B), a sensible balance sheet (debt/equity 0.36), and a market cap of ~$158B that prices growth at roughly 17x earnings. I like a tactical long into strength with a mid-term horizon (45 trading days), but momentum is soft and geopolitical supply shifts c…
Mayville Engineering (MEC) has fallen back to $17.20 after a sharp sell-off that looks disconnected from its balance-sheet resilience, revenue multiple and end-market exposure. With a market cap near $438M, positive working capital, modest leverage and a P/S of 0.75, the risk/reward for a mid-term rebound is attractive. This trade idea lays out an …
Shares of lululemon have been pummeled into the mid-$90s amid weak comps, a product refresh pivot and headline risk. The market is pricing a prolonged earnings slump, but multiples and cash flow argue for an asymmetric risk/reward. This trade offers an entry near current levels with a clear stop and a mid-term target tied to a realistic rerating.
Warren Buffett has relinquished the chairman role while Greg Abel continues running operations. With a $1.09T market cap, low leverage and strong cash generation ($24.2B free cash flow), Berkshire becomes more of a yield-and-allocation story as higher rates increase the optionality of its cash hoard. This trade targets a measured upside to $560 wit…
GH Research (GHRS) is a clinical-stage biotech with a differentiated 5-MeO-DMT program (GH001) that produced a 73% remission rate at six months in Phase 2b. Regulatory progress on the IND and continued data flow position GHRS to re-rate if the company clears the remaining preclinical issues and advances to a pivotal program. This is a high-risk, hi…
Broadcom's combination of AI-focused semiconductor strength, fat free cash flow, shareholder returns and durable software franchises makes the current pullback a buying opportunity. This trade idea lays out an entry, stop, targets, catalysts and the risks to watch over a 180-trading-day holding period.
QXO is trading below stated book value while digesting a $17B TopBuild acquisition that enlarged scale but increased complexity. Strong liquidity ratios, manageable leverage and positive free cash flow give the company runway; the market has discounted execution and margin risk. This trade idea takes a tactical long on the expectation that near-ter…
Brown & Brown has shrugged off a year-long share-price slide even as acquisitions and commission growth are driving margin expansion. Balance-sheet leverage and higher interest costs are real headwinds, but the company’s $1.45B free cash flow, accretive M&A pipeline, and still-reasonable valuation create a tradeable long setup for the next 45 tradi…
RLX Technology has pulled back to near-term lows while trading at a sub-1 PB and a P/E of ~14.6. Technicals are oversold (RSI ~28.7) and short interest is elevated, creating a favorable asymmetric trade setup. We lay out an actionable swing trade with entry, stop, and target plus catalysts and risks.
SentinelOne's recent beats, 23% ARR growth and improving free cash flow create a plausible catalyst for multiple expansion. At a market cap near $7.8B and a P/S of ~7.1x, the stock looks priced for sustained growth rather than perfection. This trade targets a rerating over a 180-trading-day window while containing downside with a disciplined stop.
Southwest Airlines (LUV) is trading near $41 with a market cap of ~$20B. Strong travel demand has let the carrier raise fares repeatedly while buybacks and a modest dividend support shareholder returns. Rising jet fuel is the obvious near-term headwind, but valuation (EV/EBITDA ~8.5, P/E ~24) and improving technicals make a tactical long trade attr…
PUIG Brands ADR ($9.60) has traded lower since high-profile takeover chatter earlier this year. Fundamentals in the luxury-beauty space remain constructive — Puig reported revenue north of €5bn in 2025 — while technicals show the ADR below near-term moving averages and with elevated short activity. This trade idea takes a controlled long exposure a…
Generac's Amazon announcement on 09/17/2026 sent shares higher on an $8 billion headline. That figure is a contingent ceiling; the committed initial deliveries are $2.4 billion in 2027-2028 and the company already shows a $1.6 billion data-center backlog. Fundamentals - $290.6M in FCF, EV $13.3B, and a current market cap near $12.25B - justify a ta…
PrimeEnergy has transformed itself into a compact, cash-generative oil & gas operator with no bank debt, high free cash flow and an aggressively reduced share count. That combination makes the equity less volatile on a per-share basis and gives buybacks real bite. We prefer a long stance into resolution of Permian operational issues and further rep…
SentinelOne's Singularity platform is converting initial endpoint wins into broader product adoption, producing steady ARR expansion and beating near-term estimates. The stock sits near its 52-week high with constructive technicals and concentrated short interest — a setup that favors a disciplined mid-term long (45 trading days) with clear entry, …
Oracle's cloud infrastructure is growing at breakneck speed thanks to AI demand, but $664B in remaining performance obligations and planned multiyear capex will keep free cash flow under pressure. This trade idea buys the pullback with a disciplined stop, targeting a recovery as revenue converts and capex starts to stabilize.
Prologis (PLD) is a market-leading logistics REIT trading below its 50-day average with a 3%+ dividend yield, low leverage and steady free cash flow. The shares look attractive at $134.84 given a market cap near $129-131B, reasonable debt metrics (debt/equity ~0.68), and a business benefit from secular e-commerce and supply-chain reconfiguration. O…
Amprius Technologies makes some of the highest energy-density lithium-ion cells on the market using silicon nanowire anodes. That proprietary advantage matters most where weight and energy density directly translate into capability - military drones, advanced EV segments and aviation. The company still posts losses and negative free cash flow, so t…
Nano Labs (NA) is a speculative small-cap that combines an AI/chip pivot with heavy cryptocurrency exposure. H1 2026 results showed a 66% revenue collapse and a US$46.5m net loss driven largely by a RMB250.5m write-down tied to BNB fair value changes. With a market cap of roughly $52.7m, negative earnings, thin liquidity and mixed technicals, the s…
Journey Medical (DERM) is a commercial-stage dermatology company whose recent FDA-approved rosacea drug, Emrosi, could be the growth engine that re-rates the stock. At a $206M market cap and EV/Sales near 3.1x, the company already sells branded dermatology products and has a manageable balance sheet. This trade idea lays out a long trade with an en…
